ResMed (RMD) Reports Mixed Q1 Earnings
ResMed Inc. (NYSE: RMD) reports Q1 EPS of $0.38, 1 cents lower than the analyst estimate of $0.39. Revenues for the quarter were $235.2 million, versus the consensus of $219.95 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
